Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial

Current Medical Research and Opinion

Volumn 27, Issue 5, 2011, Pages 1049-1058

  Barzilai, Nir ^a   Guo, Hua ^a   Mahoney, Erin M ^a   Caporossi, Suzanne ^a   Golm, Gregory T ^a   Langdon, Ronald B ^a   Williams Herman, Debora ^a   Kaufman, Keith D ^a   Amatruda, John M ^a   Goldstein, Barry J ^a   Steinberg, Helmut ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

DPP 4 inhibitor; Elderly; Glycemic control; Incretins; Sitagliptin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; SITAGLIPTIN;

ABDOMINAL PAIN; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPOGLYCEMIA; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SINUSITIS; TREATMENT OUTCOME; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VOMITING;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DOUBLE-BLIND METHOD; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PYRAZINES; TIME FACTORS; TRIAZOLES;

EID: 79954508355     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.568059     Document Type: Article

References (26)

1. Abbatecola AM, Maggi S, Paolisso G. New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies. Drugs Aging 2008;25:913-25.
2. Rosenstock J. Management of type 2 diabetes mellitus in the elderly: special considerations. Drugs Aging 2001;18:31-44. (Pubitemid 32182131)
3. Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997;20:135-41. (Pubitemid 27051549)
4. Amiel SA, Dixon T, Mann R, et al. Hypoglycaemia in type 2 diabetes. Diabet Med 2008;25:245-54. (Pubitemid 351322690)
5. GLUCOPHAGE- package insert. Available at: http://packageinserts.bms.com/ pi/pi-glucophage.pdf. Accessed May 12, 2010.
6. Grey A. Skeletal consequences of thiazolidinedione therapy. Osteoporos Int 2008;19:129-37.
7. Loke YK, Singh S, Furberg CD. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ 2009;180:32-9.
8. Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract 2008;14:750-6.
9. Singh I, Marshall Jr MC. Diabetes mellitus in the elderly. Endocrinol Metab Clin North Am 1995;24:255-72.
10. McNay EC. The impact of recurrent hypoglycemia on cognitive function in aging. Neurobiol Aging 2005;26(Suppl 1):76-9.
11. Kim D, Wang L, Beconi M, et al. (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6- dihydro[ 1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan- 2- amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem 2005;48:141-51. (Pubitemid 40105255)
12. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368:1696-705. (Pubitemid 46048557)
13. Chan JC, Scott R, Arjona Ferreira JC. Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency. Diabetes Obes Metab 2008;10:545-55. (Pubitemid 351850898)
14. Dhillon S. Sitagliptin: a review of its use in the management of type 2 diabetes mellitus. Drugs 2010;70:489-512.
15. Williams-Herman D, Engel SS, Round E, et al. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord 2010;10:7.
16. Aschner P, Kipnes MS, Lunceford JK, et al. Effect of the dipeptidyl peptidase- 4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 2006;29:2632-7. (Pubitemid 44912190)
17. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19. (Pubitemid 15018832)
18. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10. (Pubitemid 32269192)
19. Dungan KM, Buse JB, Largay J, et al. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 2006; 29:1214-19. (Pubitemid 44125912)
20. Newcombe RG. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med 1998;17:2635-50. (Pubitemid 28510655)
21. Mykkä nen L, Zaccaro DJ, Hales CN, et al. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study. Diabetologia 1999;42:1060-6.
22. Charbonnel B, Karasik A, Liu J, et al.; Sitagliptin Study 020 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. Diabetes Care 2006; 29:2638-43. (Pubitemid 44912191)
23. Raz I, Hanefeld M, Xu L, Caria C, et al.; Sitagliptin Study 023 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia 2006; 49:2564-71.
24. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004;99:750-9. (Pubitemid 38612817)
25. Herman GA, Bergman A, Stevens C, et al. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab 2006;91:4612-19. (Pubitemid 44833446)
26. Lipscombe LL, Gomes T, Lé vesque LE, et al. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA 2007;298:263-443